SHANNON FITZPATRICK: Open Payments
NPI 1639700503 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 22 payments from 6 companies in 2025. Trend: 2023 $71 · 2024 $730 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $191 |
| AERIN MEDICAL INC. | 7 | $175 |
| Regeneron Healthcare Solutions, Inc. | 4 | $115 |
| DePuy Synthes Sales Inc. | 1 | $37 |
| Optinose US, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: DUPIXENT, VIVAER STYLUS, EMBOGUARD, Xhance, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
